Clinical Trials Logo
  1. Home
  2. Normal Eyes
  3. NCT02045823

OCT Agreement and Precision Study

Normal Eyes Clinical Trial

Official title:
Topcon 3D OCT-1 Maestro and 3D OCT-2000 Optical Coherence Tomography Systems: Agreement and Precision Study

Clinical Trial Summary

To demonstrate clinical substantial equivalence of 3D OCT-1 Maestro as comparable to the commercially available iVue and NW-300. Also, to demonstrate clinical substantial equivalence of 3D OCT-2000 Maestro as comparable to the commercially available NW-300.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02045823
Study type Observational
Source Topcon Corporation
Contact
Status Completed
Phase
Start date January 2014
Completion date March 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT04604002 - Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types
Completed NCT02856139 - Appearance of Far Peripheral Retina in Normal Eyes by Ultra-widefield Fluorescein Angiography N/A
Active, not recruiting NCT05844852 - P200TE US Reference Database Study N/A
Completed NCT05792046 - IMOvifa Perimeter Reference Database
Completed NCT03279939 - Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module N/A
Completed NCT04068818 - The Heidelberg Engineering ANTERION Imaging Agreement Study
Terminated NCT03530449 - Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module